An ELISA Assay for Quantifying Monomeric C-Reactive Protein in Plasma

Native C-reactive protein (nCRP) is a non-specific marker of inflammation being claimed as a bystander in several chronic disorders. Accumulating evidence indicates that nCRP dissociates to and acts primarily as the monomeric conformation (mCRP) at inflammatory loci. This suggests that mCRP may be a superior disease marker with improved specificity and clear causality to the underlying pathogenesis. However, the lack of a feasible assay to quantify mCRP in clinical samples precludes the assessment of that suggestion. Here we report the development of a sandwich ELISA assay for quantification of plasma mCRP using commercially available reagents. Our assay is reproducible and highly conformation-specific showing a reliable detection limit of 1 ng/mL. We further show that mCRP appears to be a better marker than nCRP in several skin-related autoimmune disorders. This assay thus provides a useful tool to examine the clinical significance and utility of mCRP.

[1]  Qifeng Bai,et al.  An Intrinsically Disordered Motif Mediates Diverse Actions of Monomeric C-reactive Protein* , 2016, The Journal of Biological Chemistry.

[2]  H. Bannasch,et al.  A conformational change of C-reactive protein in burn wounds unmasks its proinflammatory properties. , 2014, International immunology.

[3]  W. Lu,et al.  Cell membranes and liposomes dissociate C‐reactive protein (CRP) to form a new, biologically active structural intermediate: mCRPm , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  G. Vilahur,et al.  Monomerization of C‐reactive protein requires glycoprotein IIb‐IIIa activation: pentraxins and platelet deposition , 2013, Journal of thrombosis and haemostasis : JTH.

[5]  T. D. Clos.  Pentraxins: structure, function, and role in inflammation. , 2013 .

[6]  J. Filep,et al.  C-reactive protein and inflammation: conformational changes affect function , 2015, Biological chemistry.

[7]  S. Ji,et al.  Regulated conformation changes in C-reactive protein orchestrate its role in atherogenesis , 2013 .

[8]  B. Nordestgaard,et al.  Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer , 2011, Critical reviews in clinical laboratory sciences.

[9]  H. Gewurz,et al.  Localization of sequence-determined neoepitopes and neutrophil digestion fragments of C-reactive protein utilizing monoclonal antibodies and synthetic peptides. , 1992, Molecular immunology.

[10]  A. Agrawal,et al.  The connection between C‐reactive protein and atherosclerosis , 2008, Annals of medicine.

[11]  M. Entman,et al.  Plasma Levels of Endothelial Microparticles Bearing Monomeric C-reactive Protein are Increased in Peripheral Artery Disease , 2016, Journal of Cardiovascular Translational Research.

[12]  A. Blom,et al.  Monomeric C‐reactive protein modulates classic complement activation on necrotic cells , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  P. Ridker.  From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To Identify Novel Targets for Atheroprotection. , 2016, Circulation research.

[14]  J. Krupiński,et al.  A role for monomeric C-reactive protein in regulation of angiogenesis, endothelial cell inflammation and thrombus formation in cardiovascular/cerebrovascular disease? , 2009, Histology and histopathology.

[15]  A. Murphy,et al.  Dissociation of Pentameric to Monomeric C-Reactive Protein on Activated Platelets Localizes Inflammation to Atherosclerotic Plaques , 2009, Circulation research.

[16]  L. Badimón,et al.  Monomeric C-reactive protein is prothrombotic and dissociates from circulating pentameric C-reactive protein on adhered activated platelets under flow. , 2011, Cardiovascular research.

[17]  J. Liao,et al.  Genetically elevated C-reactive protein and ischemic vascular disease , 2009, Current atherosclerosis reports.

[18]  P. Xu,et al.  C-reactive protein enhances activation of coagulation system and inflammatory response through dissociating into monomeric form in antineutrophil cytoplasmic antibody-associated vasculitis , 2015, BMC Immunology.

[19]  H. Bannasch,et al.  Targeting C-Reactive Protein in Inflammatory Disease by Preventing Conformational Changes , 2015, Mediators of inflammation.

[20]  T. D. Du Clos.  Pentraxins: Structure, Function, and Role in Inflammation , 2013, ISRN inflammation.

[21]  S. Reed,et al.  Membrane curvature recognition by C-reactive protein using lipoprotein mimics. , 2012, Soft matter.

[22]  R. Virmani,et al.  Dissociation of Pentameric to Monomeric C-Reactive Protein Localizes and Aggravates Inflammation: In Vivo Proof of a Powerful Proinflammatory Mechanism and a New Anti-Inflammatory Strategy , 2014, Circulation.

[23]  Mark B Pepys,et al.  C-reactive protein: a critical update. , 2003, The Journal of clinical investigation.

[24]  P. Charbel Issa,et al.  Complement Regulation at Necrotic Cell Lesions Is Impaired by the Age-Related Macular Degeneration-Associated Factor-H His402 Risk Variant , 2011, The Journal of Immunology.

[25]  K. Peter,et al.  Circulating microparticles generate and transport monomeric C-reactive protein in patients with myocardial infarction. , 2012, Cardiovascular research.

[26]  Xin Wu,et al.  Increased monomeric CRP levels in acute myocardial infarction: a possible new and specific biomarker for diagnosis and severity assessment of disease. , 2015, Atherosclerosis.

[27]  S. Bojesen,et al.  C-reactive protein and the risk of cancer: a mendelian randomization study. , 2010, Journal of the National Cancer Institute.

[28]  J. Filep,et al.  Solubilization and purification of recombinant modified C-reactive protein from inclusion bodies using reversible anhydride modification , 2015, Biophysics reports.

[29]  H. Gewurz,et al.  Antigenic, electrophoretic and binding alterations of human C-reactive protein modified selectively in the absence of calcium. , 1983, Molecular immunology.

[30]  A. Agrawal,et al.  Identification of Acidic pH-dependent Ligands of Pentameric C-reactive Protein* , 2010, The Journal of Biological Chemistry.

[31]  H. Gewurz,et al.  Identification and partial characterization of multiple native and neoantigenic epitopes of human C-reactive protein by using monoclonal antibodies. , 1989, Journal of immunology.

[32]  K. Peter,et al.  Amyloid Plaques Dissociate Pentameric to Monomeric C‐Reactive Protein: A Novel Pathomechanism Driving Cortical Inflammation in Alzheimer's Disease? , 2012, Brain pathology.